Theracare Pain Relief

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including arthritis, simple backache, strains, sprains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 2 years and older, the recommended application is to the affected area not more than 3 to 4 times daily. It is important to ensure that the application is limited to the specified frequency to avoid potential adverse effects.

For children under 2 years of age, the product should not be used unless directed by a physician. Healthcare professionals are advised to consult with a doctor for appropriate guidance in such cases.

Contraindications

The product should not be applied to wounds or damaged skin due to the potential for irritation or adverse reactions. Additionally, it is contraindicated to bandage tightly, as this may impede circulation and lead to further complications.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from fire or flame. Users should refrain from using the product while smoking and must not puncture or incinerate the container, as it is under pressure.

When utilizing this product, it is essential to avoid contact with the eyes. Application should not occur on wounds or damaged skin, and users should refrain from tightly bandaging the area where the product is applied.

Healthcare professionals should advise patients to discontinue use and seek medical attention if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted without delay.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and is flammable; therefore, it should be kept away from fire or flame. Users are advised not to use the product while smoking, and to avoid puncturing or incinerating the container, as it is under pressure.

While using this product, patients should take care to avoid contact with the eyes and should not apply it to wounds or damaged skin. Additionally, it is recommended that the product not be bandaged tightly.

Patients are instructed to stop use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days.

It is crucial to keep this product out of the reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or the Poison Control Center (1-800-222-1222) should be contacted.

Drug Interactions

There are currently no documented drug interactions associated with the use of this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Theracare Pain Relief (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center (1-800-222-1222) should be contacted.

For adults and children aged 2 years and older, the medication may be applied to the affected area no more than 3 to 4 times daily. However, the use of this medication is not recommended for children under 2 years of age; consultation with a healthcare professional is advised in such cases.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

Due to the lack of data, it is advisable to closely monitor elderly patients for any potential adverse effects or changes in therapeutic response. Individualized assessment and consideration of the patient's overall health status and comorbidities are recommended when determining the appropriateness of this medication for geriatric patients.

Pregnancy

The product does not provide specific information regarding its use during pregnancy. There are no stated contraindications or warnings related to pregnancy in the available data. Additionally, no dosage modifications for pregnant individuals are mentioned, and no special precautions regarding use during pregnancy are included in the prescribing information. Healthcare professionals should consider the absence of data when advising pregnant patients and weigh the potential benefits against any unknown risks.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help without delay. It is recommended to contact a Poison Control Center at 1-800-222-1222 for expert guidance on managing the situation.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Healthcare providers should be prepared to assess the patient's condition and implement appropriate management strategies based on the severity of symptoms and the specific substance involved.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed. Patients should be informed to discontinue use and consult a doctor if their condition worsens or if symptoms persist for more than 7 days, or if symptoms clear up and then reoccur within a few days.

It is important for healthcare providers to instruct patients to avoid contact with the eyes while using this product. Additionally, patients should be cautioned against applying the product to wounds or damaged skin. Providers should also emphasize that the product should not be bandaged tightly during use.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product out of direct sunlight, in a cool, dry, and well-ventilated area to maintain its integrity. The storage temperature must not exceed 120°F (49°C) to ensure optimal conditions. Special handling requirements include avoiding exposure to high temperatures and ensuring proper ventilation during storage.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Theracare Pain Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)